Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modified Delphi consensus study to support and enhance Parkinson's disease management.

Journal of Parkinson's disease·2026
Same author

Detection of companion galaxies around hot dust-obscured hyper-luminous galaxy W0410-0913.

Nature communications·2022
Same author

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.

Molecular cancer·2022
Same author

Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach.

Journal of neural transmission (Vienna, Austria : 1996)·2022
Same author

Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [<sup>11</sup>C]-PHNO PET study.

Parkinsonism & related disorders·2021
Same author

Striatal dopaminergic denervation and hypomimia in Parkinson's disease.

European journal of neurology·2020

Related Experiment Video

Updated: Apr 30, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

25.7K

Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders.

P Borghammer1, K Knudsen, K Østergaard

  • 1Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus C, Denmark.

International Journal of Clinical Practice
|April 24, 2014
PubMed
Summary

Combining dopamine transporter (DaT) imaging and olfactory testing accurately differentiates Parkinson's disease (PD) from atypical parkinsonism. Hyposmia in patients with abnormal DaT scans strongly suggests iPD/DLB, improving diagnostic accuracy.

More Related Videos

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

25.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.7K

Area of Science:

  • Neurology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Dopamine transporter (DaT) imaging using single photon emission computed tomography (SPECT) is highly sensitive for detecting striatal dopaminergic denervation.
  • Distinguishing idiopathic Parkinson's disease (iPD) and dementia with Lewy bodies (DLB) from atypical parkinsonian disorders (aPD) remains challenging with DaT imaging alone.
  • Olfactory dysfunction (hyposmia) is common in iPD/DLB but typically absent in aPD, offering a potential complementary diagnostic marker.

Purpose of the Study:

  • To evaluate the diagnostic power of combining DaT imaging and olfactory testing in differentiating iPD/DLB from aPD.
  • To assess the predictive value of olfactory status in patients with abnormal DaT SPECT findings.

Main Methods:

  • A cohort of 129 patients underwent baseline [123I]FP-CIT SPECT (DaT imaging) and olfactory testing.
  • Patients were followed clinically for approximately 30 months, with final diagnosis serving as the gold standard.
  • A control group of 24 healthy individuals provided normative olfactory and DaT imaging data.

Main Results:

  • DaT imaging alone demonstrated high diagnostic performance, with 98% sensitivity and 98% specificity for dopamine-deficient disorders.
  • Combined DaT imaging and olfactory testing correctly classified 91% of patients as iPD/DLB, with a positive predictive value (PPV) of 91%.
  • The PPV for iPD/DLB increased to over 97% in patients with hyposmia; however, only 45% of aPD patients were correctly classified by the combined approach, partly due to normosmic iPD patients.

Conclusions:

  • In patients with abnormal DaT SPECT, the presence of hyposmia significantly increases the likelihood of an iPD/DLB diagnosis to over 90%.
  • Conversely, normal olfaction (normosmia) in the context of an abnormal DaT scan only raises the likelihood of aPD to approximately 50%.
  • Combining DaT imaging with olfactory testing enhances diagnostic accuracy for differentiating iPD/DLB from aPD, particularly in hyposmic individuals.